3 withdrawn. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Withdrawn 3 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Glaucoma: new trials by email Literature Review of Glaucoma trials Research Report on Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| iDropper Usability in Glaucoma Open angle glaucoma - iDropper device - Glaucoma, Open-Angle [C11.525.381.407] | Phase 1 | Withdrawn | Care Team Solutions | 2014-04-01 | 2015-12-08 | |
| Lucentis for New Onset Neovascular Glaucoma Ranibizumab (Lucentis) - Glaucoma, New Onset Glaucoma | Phase 1 / Phase 2 | Withdrawn | University of Illinois at Chicago | 2008-01-04 | 2020-02-17 | |
| Effect of an Anterior Chamber Infusion System on Trabeculectomy Outcomes Trabeculectomy with anterior chamber infusion system, Trabeculectomy without anterior chamber infusion system - Glaucoma | Phase 1 | Withdrawn | Queen's University | 2007-09-01 | 2015-09-23 |
Carotid Stenosis (1) · Glaucoma, Neovascular (1) · Glaucoma, Open-Angle (1) · Ocular Hypertension (1) · Patient Compliance (1) · Retinal Vein Occlusion (1)
Eye Diseases (3) · Ocular Hypertension (2) · Arterial Occlusive Diseases (1) · Behavior (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Carotid Artery Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Embolism and Thrombosis (1) · Health Behavior (1) · Nervous System Diseases (1) · Patient Acceptance of Health Care (1) · Retinal Diseases (1) · Thrombosis (1)
Ranibizumab (1) · Trabeculectomy (1)
Care Team Solutions (1) · Queen's University (1) · University of Illinois at Chicago (1)
Canada (1) · United States (1)
Michael Bailey, PhD (1) · Michael P Blair, MD (1) · Robert J Campbell, MD (1) · Steven Chalfin, MD (1)
R43EY023122 (1)